US FDA Guidance: Apropos of PROs

Author： Kind Paul  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.24, Iss.9, 2006-01, pp. : 833-836

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Joint pharmacogenomic data submissions guidance released by the US FDA, European Commission and the European Medicines Agency

By  

Pharmacogenomics, Vol. 7, Iss. 5, 2006-07 ,pp. : 659-661

Future Medicine

Access to resources Recommend Favorite

US FDA news

By  

Inpharma, Vol. 1, Iss. 1231, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

US FDA news

By  

Inpharma, Vol. 1, Iss. 1239, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

Recent US FDA approvals

By  

Inpharma, Vol. 1, Iss. 1242, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite

US FDA approvals

By  

Inpharma, Vol. 1, Iss. 1219, 2000-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite